ID   RIPK2_HUMAN             Reviewed;         540 AA.
AC   O43353; Q6UWF0;
DT   02-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 2.
DT   05-OCT-2010, entry version 117.
DE   RecName: Full=Receptor-interacting serine/threonine-protein kinase 2;
DE            EC=2.7.11.1;
DE   AltName: Full=CARD-containing interleukin-1 beta-converting enzyme-associated kinase;
DE            Short=CARD-containing IL-1 beta ICE-kinase;
DE   AltName: Full=RIP-like-interacting CLARP kinase;
DE   AltName: Full=Receptor-interacting protein 2;
DE            Short=RIP-2;
GN   Name=RIPK2; Synonyms=CARDIAK, RICK, RIP2;
GN   ORFNames=UNQ277/PRO314/PRO34092;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND MUTAGENESIS OF LYS-47.
RX   MEDLINE=98241596; PubMed=9575181; DOI=10.1074/jbc.273.20.12296;
RA   Inohara N., del Peso L., Koseki T., Chen S., Nunez G.;
RT   "RICK, a novel protein kinase containing a caspase recruitment domain,
RT   interacts with CLARP and regulates CD95-mediated apoptosis.";
RL   J. Biol. Chem. 273:12296-12300(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND MUTAGENESIS OF LYS-47.
RC   TISSUE=Endothelial cell;
RX   MEDLINE=98307936; PubMed=9642260; DOI=10.1074/jbc.273.27.16968;
RA   McCarthy J.V., Ni J., Dixit V.M.;
RT   "RIP2 is a novel NF-kappaB-activating and cell death-inducing
RT   kinase.";
RL   J. Biol. Chem. 273:16968-16975(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND MUTAGENESIS OF ASP-146.
RC   TISSUE=Pancreatic adenocarcinoma;
RX   MEDLINE=98381580; PubMed=9705938; DOI=10.1016/S0960-9822(07)00352-1;
RA   Thome M., Hofmann K., Burns K., Martinon F., Bodmer J.-L.,
RA   Mattmann C., Tschopp J.;
RT   "Identification of CARDIAK, a RIP-like kinase that associates with
RT   caspase-1.";
RL   Curr. Biol. 8:885-888(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   MEDLINE=22887296; PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-531, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-176, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-168; SER-176; SER-178;
RP   SER-363; SER-527; SER-529; SER-531 AND SER-539, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-531, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [12]
RP   UBIQUITINATION BY RIPK2, AND INTERACTION WITH NOD2.
RX   PubMed=19592251; DOI=10.1016/j.cub.2009.06.038;
RA   Tao M., Scacheri P.C., Marinis J.M., Harhaj E.W., Matesic L.E.,
RA   Abbott D.W.;
RT   "ITCH K63-ubiquitinates the NOD2 binding protein, RIP2, to influence
RT   inflammatory signaling pathways.";
RL   Curr. Biol. 19:1255-1263(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-168; SER-174; SER-176;
RP   SER-178; SER-332; SER-345; SER-349; SER-355; THR-360; SER-363;
RP   TYR-381; SER-393; SER-527; SER-529; SER-531 AND SER-539, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [14]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-259; VAL-268 AND ASN-313.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Activates pro-caspase-1 and pro-caspase-8. Potentiates
CC       CASP8-mediated apoptosis. Activates NF-kappa-B.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Binds to CFLAR/CLARP and CASP1 via their CARD domains.
CC       Binds to BIRC3/c-IAP1 and BIRC2/c-IAP2, TRAF1, TRAF2, TRAF5 and
CC       TRAF6. May be a component of both the TNFRSF1A and TNRFSF5/CD40
CC       receptor complex. Interacts with NOD2.
CC   -!- INTERACTION:
CC       Q96CX2:KCTD12; NbExp=1; IntAct=EBI-358522, EBI-358358;
CC       Q99623:PHB2; NbExp=1; IntAct=EBI-358522, EBI-358348;
CC       P63173:RPL38; NbExp=1; IntAct=EBI-358522, EBI-359141;
CC       P62263:RPS14; NbExp=1; IntAct=EBI-358522, EBI-352783;
CC       Q9NZ23:YA61; NbExp=1; IntAct=EBI-358522, EBI-1047727;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (Probable).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O43353-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O43353-2; Sequence=VSP_013266;
CC   -!- TISSUE SPECIFICITY: Detected in heart, brain, placenta, lung,
CC       peripheral blood leukocytes, spleen, kidney, testis, prostate,
CC       pancreas and lymph node.
CC   -!- PTM: Autophosphorylated. Phosphorylated upon DNA damage, probably
CC       by ATM or ATR.
CC   -!- PTM: Ubiquitinated; undergoes 'Lys-63'-linked polyubiquitination
CC       catalyzed by ITCH.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family.
CC   -!- SIMILARITY: Contains 1 CARD domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF027706; AAC34970.1; -; mRNA.
DR   EMBL; AF078530; AAC27722.1; -; mRNA.
DR   EMBL; AF064824; AAC25668.1; -; mRNA.
DR   EMBL; AY358813; AAQ89172.1; -; mRNA.
DR   EMBL; AY358814; AAQ89173.1; -; mRNA.
DR   EMBL; AC004003; AAC24561.1; -; Genomic_DNA.
DR   EMBL; AF117829; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC004553; AAH04553.1; -; mRNA.
DR   IPI; IPI00021917; -.
DR   IPI; IPI00554774; -.
DR   RefSeq; NP_003812.1; -.
DR   UniGene; Hs.103755; -.
DR   ProteinModelPortal; O43353; -.
DR   SMR; O43353; 13-291, 436-512.
DR   IntAct; O43353; 53.
DR   MINT; MINT-90752; -.
DR   STRING; O43353; -.
DR   PhosphoSite; O43353; -.
DR   PRIDE; O43353; -.
DR   Ensembl; ENST00000220751; ENSP00000220751; ENSG00000104312.
DR   GeneID; 8767; -.
DR   KEGG; hsa:8767; -.
DR   UCSC; uc003yee.1; human.
DR   UCSC; uc003yef.1; human.
DR   CTD; 8767; -.
DR   GeneCards; GC08P090839; -.
DR   H-InvDB; HIX0007636; -.
DR   HGNC; HGNC:10020; RIPK2.
DR   HPA; HPA015273; -.
DR   HPA; HPA016499; -.
DR   MIM; 603455; gene.
DR   PharmGKB; PA34395; -.
DR   eggNOG; prNOG04555; -.
DR   HOGENOM; HBG713959; -.
DR   HOVERGEN; HBG054242; -.
DR   InParanoid; O43353; -.
DR   OMA; IQGEEFA; -.
DR   OrthoDB; EOG9PCDBF; -.
DR   PhylomeDB; O43353; -.
DR   BRENDA; 2.7.10.2; 247.
DR   BRENDA; 2.7.11.1; 247.
DR   Pathway_Interaction_DB; nfkappabcanonicalpathway; Canonical NF-kappaB pathway.
DR   Pathway_Interaction_DB; il12_2pathway; IL12-mediated signaling events.
DR   Pathway_Interaction_DB; p75ntrpathway; p75(NTR)-mediated signaling.
DR   Reactome; REACT_11061; Signalling by NGF.
DR   Reactome; REACT_6900; Signaling in Immune system.
DR   NextBio; 32880; -.
DR   ArrayExpress; O43353; -.
DR   Bgee; O43353; -.
DR   CleanEx; HS_RIPK2; -.
DR   Genevestigator; O43353; -.
DR   GermOnline; ENSG00000104312; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0050700; F:CARD domain binding; IPI:UniProtKB.
DR   GO; GO:0030274; F:LIM domain binding; IPI:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; EXP:Reactome.
DR   GO; GO:0004871; F:signal transducer activity; TAS:ProtInc.
DR   GO; GO:0006916; P:anti-apoptosis; EXP:Reactome.
DR   GO; GO:0006915; P:apoptosis; TAS:ProtInc.
DR   GO; GO:0006954; P:inflammatory response; TAS:ProtInc.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-k...; IEP:UniProtKB.
DR   GO; GO:0031398; P:positive regulation of protein ubiquitination; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0034134; P:toll-like receptor 2 signaling pathway; IDA:MGI.
DR   InterPro; IPR001315; CARD.
DR   InterPro; IPR011029; DEATH-like.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017322; Rcpt-int_Ser/Thr_kinase-2.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   Gene3D; G3DSA:1.10.533.10; DEATH_like; 1.
DR   Pfam; PF00619; CARD; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF037921; STPK_RIP2; 1.
DR   SMART; SM00114; CARD; 1.
DR   SUPFAM; SSF47986; DEATH_like; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50209; CARD; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Apoptosis; ATP-binding; Complete proteome;
KW   Cytoplasm; Kinase; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase; Ubl conjugation.
FT   CHAIN         1    540       Receptor-interacting serine/threonine-
FT                                protein kinase 2.
FT                                /FTId=PRO_0000086608.
FT   DOMAIN       18    294       Protein kinase.
FT   DOMAIN      432    524       CARD.
FT   NP_BIND      24     32       ATP (By similarity).
FT   ACT_SITE    146    146       Proton acceptor.
FT   BINDING      47     47       ATP.
FT   MOD_RES     168    168       Phosphoserine.
FT   MOD_RES     174    174       Phosphoserine.
FT   MOD_RES     176    176       Phosphoserine.
FT   MOD_RES     178    178       Phosphoserine.
FT   MOD_RES     332    332       Phosphoserine.
FT   MOD_RES     345    345       Phosphoserine.
FT   MOD_RES     349    349       Phosphoserine.
FT   MOD_RES     355    355       Phosphoserine.
FT   MOD_RES     360    360       Phosphothreonine.
FT   MOD_RES     363    363       Phosphoserine.
FT   MOD_RES     381    381       Phosphotyrosine.
FT   MOD_RES     393    393       Phosphoserine.
FT   MOD_RES     527    527       Phosphoserine.
FT   MOD_RES     529    529       Phosphoserine.
FT   MOD_RES     531    531       Phosphoserine.
FT   MOD_RES     539    539       Phosphoserine.
FT   VAR_SEQ       1    137       Missing (in isoform 2).
FT                                /FTId=VSP_013266.
FT   VARIANT     259    259       I -> T (in dbSNP:rs2230801).
FT                                /FTId=VAR_041045.
FT   VARIANT     268    268       L -> V (in dbSNP:rs35004667).
FT                                /FTId=VAR_041046.
FT   VARIANT     313    313       K -> N (in dbSNP:rs35395048).
FT                                /FTId=VAR_041047.
FT   MUTAGEN      47     47       K->A: Abolishes kinase activity.
FT   MUTAGEN      47     47       K->M: Reduces FAS-mediated apoptosis.
FT   MUTAGEN     146    146       D->N: Abolishes kinase activity.
SQ   SEQUENCE   540 AA;  61195 MW;  575A692239505792 CRC64;
     MNGEAICSAL PTIPYHKLAD LRYLSRGASG TVSSARHADW RVQVAVKHLH IHTPLLDSER
     KDVLREAEIL HKARFSYILP ILGICNEPEF LGIVTEYMPN GSLNELLHRK TEYPDVAWPL
     RFRILHEIAL GVNYLHNMTP PLLHHDLKTQ NILLDNEFHV KIADFGLSKW RMMSLSQSRS
     SKSAPEGGTI IYMPPENYEP GQKSRASIKH DIYSYAVITW EVLSRKQPFE DVTNPLQIMY
     SVSQGHRPVI NEESLPYDIP HRARMISLIE SGWAQNPDER PSFLKCLIEL EPVLRTFEEI
     TFLEAVIQLK KTKLQSVSSA IHLCDKKKME LSLNIPVNHG PQEESCGSSQ LHENSGSPET
     SRSLPAPQDN DFLSRKAQDC YFMKLHHCPG NHSWDSTISG SQRAAFCDHK TTPCSSAIIN
     PLSTAGNSER LQPGIAQQWI QSKREDIVNQ MTEACLNQSL DALLSRDLIM KEDYELVSTK
     PTRTSKVRQL LDTTDIQGEE FAKVIVQKLK DNKQMGLQPY PEILVVSRSP SLNLLQNKSM
//
